Form 4: Vaxcyte COO Sells Shares
Insider Transaction (Form 4)
Jim Wassil, EVP, Chief Scientific Ofc, COO of Vaxcyte, Inc., sold 2,715 shares of common stock on September 4, 2026.
Summary
- Open-market sale: disposed of 1,381 Common Stock at $61.16 ($84,462) on September 4, 2026; holds 152,228 after (Direct).
- Tax/exercise-price withholding: disposed of 5,459 Common Stock at $60.36 ($329,505) on September 8, 2026; holds 146,769 after (Direct).
- Open-market sale: disposed of 1,334 Common Stock at $59.52 ($79,401) on September 9, 2026; holds 145,435 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $163,863 of stock on the open market.
Insider Transactions
Jim Wassil — Officer (EVP, Chief Scientific Ofc, COO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Common Stock | 1,381 | $61 | $84.5K | 152,228 |
| 2026-09-08 | Tax/exercise-price withholding | Common Stock | 5,459 | $60 | $329.5K | 146,769 |
| 2026-09-09 | Open-market sale | Common Stock | 1,334 | $60 | $79.4K | 145,435 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (1,381 shares) |
| 2026-09-08 | Tax/exercise-price withholding (5,459 shares) |
| 2026-09-09 | Open-market sale (1,334 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., bearish, Jim Wassil
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.